Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
70.31 USD | +0.14% | +2.43% | +12.15% |
05-22 | Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing | MT |
05-14 | Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.15% | 7.64B | |
+10.40% | 114B | |
+11.33% | 105B | |
-5.08% | 23.83B | |
-0.49% | 21.73B | |
-10.12% | 18.1B | |
-42.36% | 16.34B | |
-16.48% | 16.13B | |
+1.52% | 13.75B | |
+31.99% | 11.76B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte : Posts Smaller-Than-Expected Q3 Loss